Skip to main content
. 2015 Jan 2;5(1):25–33. doi: 10.1016/j.apsb.2014.12.006

Figure 6.

Figure 6

(a) Ex vivo image of Aβ plaques in a Tg mouse brain section treated with intravenous administration of 0.4 mg/kg DANIR 2c. (b) In vivo images of female 22-month-old wild type (top row) and APPsw/PSEN1 transgenic (bottom row) mice at different time points (2, 10, 30, 60 min) after injected with 0.4 mg/kg DANIR 2c. (Adapted with permission from Ref.60. Copyright 2014 American Chemical Society.)